140 related articles for article (PubMed ID: 20160392)
1. Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population.
Sakuma M; Nakamura M; Tanaka F; Onoda T; Itai K; Tanno K; Ohsawa M; Sakata K; Yoshida Y; Kawamura K; Makita S; Okayama A
Circ J; 2010 Apr; 74(4):792-7. PubMed ID: 20160392
[TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
[TBL] [Abstract][Full Text] [Related]
3. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific threshold levels of plasma B-type natriuretic peptide for prediction of cardiovascular event risk in a Japanese population initially free of cardiovascular disease.
Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Onodera M; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Shinichi O; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
Am J Cardiol; 2011 Dec; 108(11):1564-9. PubMed ID: 21871591
[TBL] [Abstract][Full Text] [Related]
5. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk stratification with plasma B-type natriuretic peptide levels in a community-based hypertensive cohort.
Sato K; Segawa T; Tanaka F; Takahashi T; Tanno K; Ohsawa M; Onoda T; Itai K; Sakata K; Omama S; Ogasawara K; Ishibashi Y; Makita S; Okayama A; Nakamura M
Am J Cardiol; 2014 Feb; 113(4):682-6. PubMed ID: 24388621
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
[TBL] [Abstract][Full Text] [Related]
9. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
Spanaus KS; Kronenberg F; Ritz E; Schlapbach R; Fliser D; Hersberger M; Kollerits B; König P; von Eckardstein A;
Clin Chem; 2007 Jul; 53(7):1264-72. PubMed ID: 17478561
[TBL] [Abstract][Full Text] [Related]
11. Level and Change in N-Terminal Pro-B-Type Natriuretic Peptide and Kidney Function and Survival to Age 90.
Häberle AD; Biggs ML; Cushman M; Psaty BM; Newman AB; Shlipak MG; Gottdiener J; Wu C; Gardin JM; Bansal N; Odden MC
J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):478-484. PubMed ID: 32417919
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
[TBL] [Abstract][Full Text] [Related]
13. Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.
Schneider MP; Schmid M; Nadal J; Krane V; Saritas T; Busch M; Schultheiss UT; Meiselbach H; Friedrich N; Nauck M; Floege J; Kronenberg F; Wanner C; Eckardt KU;
Kidney Med; 2023 Nov; 5(11):100725. PubMed ID: 37915964
[TBL] [Abstract][Full Text] [Related]
14. Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study.
Nakamura M; Koeda Y; Tanaka F; Onoda T; Itai K; Ohsawa M; Tanno K; Sakata K; Omama S; Ishibashi Y; Makita S; Ohta M; Ogasawara K; Komatsu T; Okayama A
PLoS One; 2013; 8(12):e81243. PubMed ID: 24312541
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide is related to carotid plaques and predicts atherosclerosis in pre-dialysis patients with chronic kidney disease.
Zhou W; Ni Z; Yu Z; Shi B; Wang Q
Eur J Intern Med; 2012 Sep; 23(6):539-44. PubMed ID: 22863432
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
Hayashi T; Yasuda K; Kimura T; Sasaki K; Shimada K; Hashimoto N; Isaka Y
Am J Nephrol; 2018; 48(3):205-213. PubMed ID: 30196305
[TBL] [Abstract][Full Text] [Related]
18. Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria.
Onodera M; Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Omama S; Ogasawara K; Ogawa A; Kuribayashi T; Sakamaki K; Okayama A
Int Heart J; 2012; 53(3):176-81. PubMed ID: 22790686
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
[TBL] [Abstract][Full Text] [Related]
20. Plasma B-type natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease.
Yoshitomi R; Nakayama M; Sakoh T; Fukui A; Shikuwa Y; Tominaga M; Tsuchihashi T; Tsuruya K; Kitazono T
J Hypertens; 2016 Apr; 34(4):753-61. PubMed ID: 26828787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
